214 related articles for article (PubMed ID: 694476)
41. Elevated fibrin(ogen) degradation products in the adult respiratory distress syndrome.
Haynes JB; Hyers TM; Giclas PC; Franks JJ; Petty TL
Am Rev Respir Dis; 1980 Dec; 122(6):841-7. PubMed ID: 6450559
[TBL] [Abstract][Full Text] [Related]
42. Fibrinopeptide A, beta-thromboglobulin, and fibrin degradation products as screening test for the diagnosis of deep vein thrombosis.
Wojciechowski J; Olausson M; Korsan-Bengtsen K
Haemostasis; 1983; 13(4):254-61. PubMed ID: 6194049
[TBL] [Abstract][Full Text] [Related]
43. Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery disease.
Eritsland J; Seljeflot I; Arnesen H; Smith P; Westvik AB
Thromb Res; 1992 Apr; 66(1):55-60. PubMed ID: 1412183
[TBL] [Abstract][Full Text] [Related]
44. Fibrin polymerization sites in fibrinogen and fibrin fragments.
Budzynski AZ; Olexa SA; Pandya BV
Ann N Y Acad Sci; 1983 Jun; 408():301-14. PubMed ID: 6575691
[No Abstract] [Full Text] [Related]
45. Fibrinopeptide A and intravascular coagulation in normotensive and hypertensive pregnancy and parturition.
Wallmo L; Karlsson K; Teger-Nilsson AC
Acta Obstet Gynecol Scand; 1984; 63(7):637-40. PubMed ID: 6516813
[TBL] [Abstract][Full Text] [Related]
46. The relationship between fibrinogen degradation products and cryofibrinogen.
Komp DM; Donaldson MH
Am J Pediatr Hematol Oncol; 1979; 1(2):99-102. PubMed ID: 543513
[TBL] [Abstract][Full Text] [Related]
47. Pleural fluid ferritin concentrations in human disease.
Klockars M; Weber T; Tanner P; Hellström PE; Pettersson T
J Clin Pathol; 1985 Jul; 38(7):818-24. PubMed ID: 4019803
[TBL] [Abstract][Full Text] [Related]
48. [Studies on the fibrinolytic system in ruptured intracranial aneurysm. Part 1. Monitoring of the antifibrinolytic therapy through repeated measurement of SK-euglobulin lysis time and FDP (author's transl)].
Watanabe H; Chigasaki H; Ishii S
No Shinkei Geka; 1977 Jul; 5(8):857-63. PubMed ID: 561325
[TBL] [Abstract][Full Text] [Related]
49. Degradation of fibrinogen by tissue plasminogen activator. Consequences for fibrin polymerization.
Mirshahi M; Soria J; Soria C; Samama M; Caen JP
Thromb Res Suppl; 1990; 10():21-6. PubMed ID: 2107597
[TBL] [Abstract][Full Text] [Related]
50. Clotting activation and impairment of fibrinolysis in malignancy.
Rocha E; Páramo JA; Fernández FJ; Cuesta B; Hernández M; Paloma MJ; Rifón J
Thromb Res; 1989 Jun; 54(6):699-707. PubMed ID: 2506659
[TBL] [Abstract][Full Text] [Related]
51. Detection of fibrin generation alterations in dogs with haemangiosarcoma using resonance thrombography.
Mischke R; Wohlsein P; Schoon HA
Thromb Res; 2005; 115(3):229-38. PubMed ID: 15617746
[TBL] [Abstract][Full Text] [Related]
52. Relations between fibrinogen degradation products and heparinocytes.
Frick G; Frick U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):271-6. PubMed ID: 61922
[TBL] [Abstract][Full Text] [Related]
53. [ON THE CHEMICAL COMPOSITION OF FIBRINOGEN AND FIBRIN. 3. GLYCIDIC COMPONENTS OF PLASMA FIBRIN AND OF SEROUS PLEURAL EFFUSIONS OF PATIENTS WITH EXUDATIVE PLEURITIS AND PULMONARY NEOPLASMS].
CHIARIONI T; BENI G; NARDI E; DIMASSIMO-SIMONETTI S
Med Clin Sper; 1964; 14():424-38. PubMed ID: 14264341
[No Abstract] [Full Text] [Related]
54. Characterisation of serum fibrinogen degradation products using gel chromatography and radioimmunoassay.
Ratky SM; Sykes A; Cooke ED; Gordon YB
Thromb Haemost; 1977 Jun; 37(3):471-6. PubMed ID: 578027
[TBL] [Abstract][Full Text] [Related]
55. Fibrin(ogen) peptides in early breast cancer.
Mannucci PM; Cugno M; Mameli G; Marongiu F; Bianchi Bonomi A
Thromb Haemost; 1989 Sep; 62(2):819. PubMed ID: 2814934
[No Abstract] [Full Text] [Related]
56. Haemostatic abnormalities and outcome in patients with operable breast cancer.
McCulloch P; Lowe GD; Douglas JT; Murray GD; George WD
Eur J Cancer; 1990; 26(9):950-3. PubMed ID: 2149020
[TBL] [Abstract][Full Text] [Related]
57. The effect of low-dose heparin on fibrinopeptide A, platelets, fibrinogen degradation products and other haemostatic parameters measured in connection with intestinal surgery.
Törngren S; Norén I; Savidge G
Thromb Res; 1979; 14(6):871-9. PubMed ID: 382435
[No Abstract] [Full Text] [Related]
58. Value of pleural lactate in the differential diagnosis between empyema and non-bacterial pleural effusions.
Bruun B; Stilbo I; Bartels P
Acta Pathol Microbiol Immunol Scand B; 1984 Apr; 92(2):85-8. PubMed ID: 6730971
[TBL] [Abstract][Full Text] [Related]
59. Fibrinopeptide A and fibrinogen fragment B beta 15-42 and their relation to the operative trauma and post-operative thromboembolism in neurosurgical patients.
Boström S; Holmgren E; Jonsson O; Lindström B; Stigendal L
Acta Neurochir (Wien); 1987; 88(1-2):49-55. PubMed ID: 2447755
[TBL] [Abstract][Full Text] [Related]
60. Effect of anticoagulant treatment measured by fibrinopeptide A (fpA) in patients with venous thrombo-embolism.
Peuscher FW; van Aken WG; Flier OT; Stoepman-van Dalen EA; Cremer-Goote TM; van Mourik JA
Thromb Res; 1980 Apr 1-15; 18(1-2):33-43. PubMed ID: 7404504
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
